课题基金 / 基金详情

Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.

Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.
Injurin/HGF 系统器官再生和稳态的分子机制。
批准号:
05404080
负责人:
NAKAMURA Toshikazu
金额:
$20.29万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

NAKAMURA Toshikazu的其他基金

相似基金

相关文献

中文摘要
翻译
(1) HGF作为器官营养因子的作用:重组HGF抑制慢性肝损伤引起的肝纤维化/肝硬化和脂肪肝的发生。我们发现HGF作为肾和肺再生的肾营养因子和肺营养因子。HGF很有可能成为治疗肝纤维化/肝硬化、急性肾功能衰竭、肺纤维化等多种器官疾病的新型治疗药物。(2) HGF作为神经营养因子:HGF在体外刺激海马神经元的存活。重要的是,注入重组HGF可显著预防大鼠缺血性损伤引起的神经元死亡。(3) HGF在上皮-间充质相互作用中的中介作用:上皮-间充质相互作用是器官发生的重要组织相互作用。在肝、肾、肺、牙、肢体等发育过程中,HGF在间质组织中表达,而c-Met/HGF受体在上皮组织中表达。HGF作为间质源性因子支持各种器官的器官发生,如肝、肾、肺、牙齿、乳腺。(4) HGF是肿瘤-基质相互作用:肿瘤细胞的恶性表型是通过与宿主基质细胞相互作用调控的。我们发现各种肿瘤细胞产生HGF诱导剂(损伤素),基质来源的HGF增强了肿瘤细胞的侵袭。肿瘤细胞与宿主间质细胞之间的相互作用介导肿瘤-间质相互作用。(5)损伤因子(hgf诱导剂)的鉴定:我们从肺组织提取物中纯化损伤因子,发现它们是IL-1、PDGF和bFGF。同样,我们确定了肿瘤源性损伤为IL-1、PDGF和bFGF。而小鼠乳腺肿瘤细胞产生了新的hgf诱导剂。相反,我们发现tgf - β和糖皮质激素是HGF表达的负调节因子。
英文摘要
(1) Roles of HGF as an organotrophic factor : Recombinant HGF suppressed the onset of liver fibrosis/cirrhosis and fatty liver caused by chronic hepatic injury. We found that HGF functions as renotrophic and pulmotrophic factor for regeneration of the kidney and lung. HGF may well become a new therapeutic drug for the treatment of various organ diseases, including liver fibrosis/cirrhosis, acute renal failure, and lung fibrosis.(2) HGF as a neurotrophic factor : HGF stimulated survival of hippocampal neurons in vitro. Importantly, the infused recombinant HGF markedly prevented neuronal death caused by ischemic injury in rats.(3) HGF as a mediator in epithelial-mesenchymal interactions : Epithelial-mesenchymal interaction is a critical tissue interaction for organogenesis. HGF is expressed in mesenchymal tissue, while c-Met/HGF receptor in epithelial tissue during development of the liver, kidney, lung tooth, limb, etc. HGF supports organogenesis of various organs, such as the liver, kidney, lung, tooth, mammary gland, as a mesenchymal-derived factor.(4) HGF is tumor-stromal interactions : Malignant phenotypes of tumor cells are regulated through their interactions with host stromal cells. We found that various tumor cells produce HGF-inducer (injurin) and stromal-derived HGF enhanced the invation of tumor cells. Matual interaction between tumor cells and host stromal cells mediate tumor-stromal interactions.(5) Identification of injurin (HGF-inducer) : We purified injurin (s) from lung tissue extract and found that these are IL-1, PDGF,and bFGF.Likewise, we identified tumor-derived injurins as IL-1, PDGF,and bFGF.But mouse mammary tumor cells produced novel HGF-inducer. In contrast, we found that TGF-beta and glucocorticoids are negative regulator of HGF expression.
期刊论文(353)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
G.Shiota: "Hepatocyte growth factor accelerates liver regeneration and causes a hepatoproliferative disorder in transgenic mice." Hepatology. (in press). (1994)
G.Shiota:“肝细胞生长因子可加速肝脏再生,并导致转基因小鼠出现肝增殖性疾病。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
G.Shiota: "Autocrine stimulation of glioblastoma cells resulting from expression of c-met and the met-ligand(Scatter factor/Hepatocyte growth factor)." Oncogene. (in press). (1994)
G.Shiota:“c-met 和 met-配体(分散因子/肝细胞生长因子)的表达导致胶质母细胞瘤细胞的自分泌刺激。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
J.Wojta: "Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells in culture." Blood. 84. 151-157 (1994)
J.Wojta:“肝细胞生长因子可刺激培养的 HepG2 细胞中 1 型纤溶酶原激活剂抑制剂和组织因子的表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 298 条
    DISTANCE MEASUREMENTS OF FIBROUS PRION PROTEINS BY PULSE ESR SPECTROSCOPY
    • 批准号:
      24654112
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Analysis of molecular mechanisms that reciprocally regulate growth and differentiation of mature hepatocytes
    • 批准号:
      21390079
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2009
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Investigation of Spin Dynamics and Development of Devices for Low-Dimensional Electronic Phases
    • 批准号:
      20340095
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.49万
    • 财政年份:
      2008
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Molecular Mechanisms of Tissue Regeneration through the Conversion of HGF Receptor Signaling in Response of Injury
    • 批准号:
      18390087
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.57万
    • 财政年份:
      2006
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    国内基金
    海外基金
    金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
    • 批准号:
      2026JJ81256
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李弘德
    • 依托单位:
    复方香巴戟膏介导的NO/HGF/c-met通路活化卫星细胞促进损伤后肌肉组织再生
    • 批准号:
      2025JJ70694
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      丁轩
    • 依托单位:
    人工智能辅助c-Met靶向放射性诊疗药物的发现及其临床转化研究
    解毒化瘀颗粒靶向THBS1重塑ECM激活HGF/c-Met路径以促进肝再生拮抗肝衰竭的“时—空”轨迹与分子机制研究
    • 批准号:
      82560906
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      33.00万元
    • 批准年份:
      2025
    • 负责人:
      王明刚
    • 依托单位: